Net income · 2011–2025
Sinovac Biotech net income
−$199M−$239M · FY2025
Sinovac Biotech (SVA) reported −$199M in net income for fiscal 2025, −$239M from the year before.
| Fiscal year | Net income | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | −$199M | −$239M | Open → |
| FY20242024-12-31 | $40.7M | +$54.1M | Open → |
| FY20232023-12-31 | −$13.5M | −$28.0M | Open → |
| FY20222022-12-31 | $14.5M | −99.8% | Open → |
| FY20212021-12-31 | $8.1B | +7,259.1% | Open → |
| FY20202020-12-31 | $110M | +145.7% | Open → |
| FY20192019-12-31 | $44.9M | +106.3% | Open → |
| FY20182018-12-31 | $21.8M | −15.6% | Open → |
| FY20172017-12-31 | $25.8M | +$26.4M | Open → |
| FY20162016-12-31 | −$596,000 | +$820,000 | Open → |
| FY20152015-12-31 | −$1.4M | +$99,000 | Open → |
| FY20142014-12-31 | −$1.5M | −$9.0M | Open → |
| FY20132013-12-31 | $7.4M | +$26.2M | Open → |
| FY20122012-12-31 | −$18.7M | −$17.9M | Open → |
| FY20112011-12-31 | −$844,696 | — | Open → |
Net income — Net income is profit after tax and all expenses, as reported in the annual filing. Companies reporting a loss are excluded from this ranking.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Net income at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Sinovac Biotech net income |url=https://companiesranked.com/en/company/sinovac-biotech/net-income |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Sinovac Biotech net income. CompaniesRanked. https://companiesranked.com/en/company/sinovac-biotech/net-incomeBibTeX
@misc{companiesranked-en-company-sinovac-biotech-net-income-2026,
author = {{CompaniesRanked}},
title = {{Sinovac Biotech net income}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/sinovac-biotech/net-income}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001193125-26-258534 · June 5, 2026
{{cite web |title=Sinovac Biotech net income — 20-F (0001193125-26-258534) |url=https://www.sec.gov/Archives/edgar/data/1084201/000119312526258534/sva-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-06-05}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.